Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

Similar articles for PubMed (Select 19149716)

1.

Individual triptan selection in migraine attack therapy.

Belvís R, Pagonabarraga J, Kulisevsky J.

Recent Pat CNS Drug Discov. 2009 Jan;4(1):70-81. Review.

PMID:
19149716
2.

Migraine attack treatment : a tailor-made suit, not one size fits all.

Belvis R, Mas N, Aceituno A.

Recent Pat CNS Drug Discov. 2014 Apr;9(1):26-40. Review.

PMID:
24605940
3.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Ferrari MD, Goadsby PJ, Roon KI, Lipton RB.

Cephalalgia. 2002 Oct;22(8):633-58. Erratum in: Cephalalgia. 2003 Feb;23(1):71..

PMID:
12383060
4.

Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

McCormack PL, Foster RH.

Pharmacoeconomics. 2005;23(12):1283-98. Review.

PMID:
16336021
5.

[Clinical use of triptans in the management of migraine].

Lantéri-Minet M.

CNS Drugs. 2006;20 Spec no.1:12-23. Review. French.

PMID:
16841523
6.

Frovatriptan: a review of its use in the acute treatment of migraine.

Sanford M.

CNS Drugs. 2012 Sep 1;26(9):791-811. doi: 10.2165/11209380-000000000-00000. Review.

PMID:
22900951
7.

Triptans for the management of migraine.

Johnston MM, Rapoport AM.

Drugs. 2010 Aug 20;70(12):1505-18. doi: 10.2165/11537990-000000000-00000. Review.

PMID:
20687618
8.

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Tfelt-Hansen P, De Vries P, Saxena PR.

Drugs. 2000 Dec;60(6):1259-87. Review.

PMID:
11152011
9.

The use of triptans for pediatric migraines.

Eiland LS, Hunt MO.

Paediatr Drugs. 2010 Dec 1;12(6):379-89. doi: 10.2165/11532860-000000000-00000. Review.

PMID:
21028917
10.

Newer formulations of the triptans: advances in migraine management.

Gladstone JP, Gawel M.

Drugs. 2003;63(21):2285-305. Review.

PMID:
14524731
11.
12.

Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.

Mullins CD, Subedi PR, Healey PJ, Sanchez RJ.

Pharmacotherapy. 2007 Aug;27(8):1092-101.

PMID:
17655509
13.

Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.

Guidotti M, Ravasio R.

Clin Drug Investig. 2009;29(11):693-702. doi: 10.2165/11315330-000000000-00000. Review.

PMID:
19813772
14.

Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.

Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D.

Headache. 2007 Sep;47(8):1152-68. Review.

PMID:
17883520
15.

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Ferrari MD, Roon KI, Lipton RB, Goadsby PJ.

Lancet. 2001 Nov 17;358(9294):1668-75.

PMID:
11728541
16.

Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.

Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ.

Cephalalgia. 2014 Apr;34(4):258-67. doi: 10.1177/0333102413508661. Epub 2013 Oct 9.

PMID:
24108308
17.

Spotlight on eletriptan in migraine.

McCormack PL, Keating GM.

CNS Drugs. 2006;20(11):961-4. Review.

PMID:
17044732
18.

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.

Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.

Headache. 2004 Jul-Aug;44(7):661-8.

PMID:
15209687
19.

Eletriptan: a review of its use in the acute treatment of migraine.

McCormack PL, Keating GM.

Drugs. 2006;66(8):1129-49. Review.

PMID:
16789799
20.

Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.

Pascual J, Fité B, López-Gil A.

Headache. 2002 Feb;42(2):93-8.

PMID:
12005301
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk